about
Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaCSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site.Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancerIdentification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.Multiple mechanisms mediate resistance to sorafenib in urothelial cancerPathobiology and chemoprevention of bladder cancerMouse models of human bladder cancer as a tool for drug discovery.Inactivation of p53 and Pten promotes invasive bladder cancerMetformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.DNA methylation-based biomarkers in bladder cancer.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Bladder cancers arise from distinct urothelial sub-populations.The use of regenerative medicine in the management of invasive bladder cancer.Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
P2860
Q26860953-5DE31D39-C184-4524-BD00-AC01CA72CD0CQ31120339-85E749D7-B5C7-4B8B-AB4B-7A10B6A616FFQ33554443-51C6F67E-9DE8-450F-A1F6-C85C702F88ADQ34674350-BD11C96F-F9B5-4A83-A942-D71B2DA569B6Q34685436-040E186B-00E8-4CCA-A511-32F6861461A0Q35219328-F8F701BB-C61B-4CAF-99C2-153E6EF3C398Q35738385-BB7EAB47-6F12-4B1F-B0F6-EF00578D805EQ37141814-CC6AE90B-632E-4C2D-A755-B5A734C6B199Q37317523-1C8D0BFF-C715-4B3F-AB47-501F8BDC3D5AQ37797468-0F93A095-1FFA-4F84-856E-DBC19A478A2EQ38102879-AB75B978-C734-43E1-8782-D47A640F1519Q38297729-7CB1A8F3-E065-4E6E-BFCF-56D5CDDF3B38Q42465565-9986795F-9186-4A17-A521-1E632B7D8A5BQ42679818-F9D2061F-5A84-4D57-85EB-EE8C6D58E602Q44322023-A447B9B0-F3B2-430A-A345-2FADABAF4398Q45221749-24F899F3-157D-4D7A-89A8-DB0CA35728A5
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bladder cancer subtypes defined by genomic alterations.
@en
Bladder cancer subtypes defined by genomic alterations.
@en-gb
Bladder cancer subtypes defined by genomic alterations.
@nl
type
label
Bladder cancer subtypes defined by genomic alterations.
@en
Bladder cancer subtypes defined by genomic alterations.
@en-gb
Bladder cancer subtypes defined by genomic alterations.
@nl
prefLabel
Bladder cancer subtypes defined by genomic alterations.
@en
Bladder cancer subtypes defined by genomic alterations.
@en-gb
Bladder cancer subtypes defined by genomic alterations.
@nl
P2860
P1476
Bladder cancer subtypes defined by genomic alterations.
@en
P2860
P304
P356
10.1080/03008880802284605
P577
2008-09-01T00:00:00Z